List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 134 studies with search of: Abacavir OR Ziagen[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine
2 Completed Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
Condition: HIV Infection
Intervention: Drug: abacavir
3 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
4 Completed A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine
5 Completed A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate;   Drug: Efavirenz
6 Completed A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Condition: HIV Infection
Intervention: Drug: Abacavir/Lamivudine
7 Active, not recruiting Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate
8 Active, not recruiting Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Lamivudine;   Drug: Zidovudine
9 Recruiting Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
10 Completed Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
Condition: HIV Infection
Intervention: Drug: Abacavir
11 Active, not recruiting A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Zidovudine
12 Active, not recruiting KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
Condition: HIV Infection
Intervention: Drug: Abacavir/Lamivudine, Tenofovir/Emtricitabine
13 Completed Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC
Condition: HIV Infections
Interventions: Drug: Abacavir;   Drug: Didanosine;   Drug: Abacavir+Lamivudine
14 Completed Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Abacavir sulfate
15 Completed Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
Condition: HIV Infection
Interventions: Drug: Abacavir;   Drug: Amprenavir;   Drug: Efavirenz
16 Active, not recruiting Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: GW433908
17 Completed Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: Abacavir+lamivudine
18 Completed New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine;   Drug: tenofovir
19 Completed A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz
20 Completed An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services